TCL Archive In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving December 6, 1996
TCL Archive NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands October 15, 1999
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
